Ditchcarbon
  • Customers
  1. Organizations
  2. Yuhan Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
KR
updated 10 days ago

Yuhan Corporation

Company website

Yuhan Corporation, a leading pharmaceutical company based in South Korea (KR), has been at the forefront of the industry since its establishment in 1926. With its headquarters in Seoul, Yuhan operates extensively across Asia, Europe, and North America, focusing on innovative drug development and manufacturing. Specialising in prescription pharmaceuticals, over-the-counter products, and biopharmaceuticals, Yuhan is renowned for its commitment to research and development, which has led to significant advancements in oncology, cardiology, and infectious diseases. The company has achieved notable milestones, including strategic partnerships and a robust pipeline of new therapies, solidifying its position as a key player in the global market. Yuhan Corporation's dedication to quality and innovation continues to drive its success, making it a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Yuhan Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Yuhan Corporation's score of 35 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

57%

Let us know if this data was useful to you

Yuhan Corporation's reported carbon emissions

In 2023, Yuhan Corporation reported total carbon emissions of approximately 7,756,000 kg CO2e for Scope 1 and about 16,818,000 kg CO2e for Scope 2, resulting in a combined total of around 24,564,000 kg CO2e for both scopes. This marks a slight decrease from 2022, where emissions were approximately 7,819,000 kg CO2e for Scope 1 and about 16,191,000 kg CO2e for Scope 2, totalling around 24,000,000 kg CO2e. In 2021, the company recorded emissions of about 7,492,000 kg CO2e for Scope 1 and approximately 15,246,000 kg CO2e for Scope 2, leading to a total of around 22,724,000 kg CO2e. Yuhan Corporation has committed to achieving net-zero greenhouse gas emissions by 2050, as part of its long-term climate strategy initiated in 2023. This commitment reflects the company's recognition of the urgent need for global cooperation in addressing climate change. Currently, Yuhan has not disclosed any Scope 3 emissions data, nor does it have specific Science-Based Targets Initiative (SBTi) targets. Overall, Yuhan Corporation is actively working towards reducing its carbon footprint while aligning with global climate goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202120222023
Scope 1
7,492,000
0,000,000
0,000,000
Scope 2
15,246,000
00,000,000
00,000,000
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Yuhan Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Yuhan Corporation is in KR, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Yuhan Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hisun Pharmaceutical

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Bio-Thera Solutions, Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Shandong New Time Pharmaceutical Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Zai Lab

CN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Mabwell Therapeutics, Inc.

US
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy